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ABSTRACT. The objective of the current study was to investigate the effect of serum progesterone concentration, ei-
ther endogenous, during the ovarian cycle and pregnancy, or exogenous, when administered during anestrus, and of its 
active metabolite allopregnanolone, on anesthetic and analgesic requirements, as well as post-operative pain intensity, 
for the performance of ovariohysterectomy in dogs. One hundred and fifty healthy female dogs, which were admitted 
to our clinic for elective ovariohysterectomy, were included in the present study. They were allocated to 6 groups ac-
cording to the stage of the ovarian cycle and the corresponding serum progesterone concentration. The six groups con-
sisted of dogs in anestrus (group A), in anestrus which received intramuscular progesterone injections prior to surgery 
(group Ap), dogs in diestrus (group D), in diestrus which received subcutaneous aglepristone injections prior to surgery 
(group Da), in diestrus which received oral trilostane prior to surgery (group Dt) and dogs in pregnancy of duration of 
28-42 days (group P). Serum progesterone concentrations were measured in all dogs before and after any hormonal 
treatment and serum allopregnanolone concentrations were measured in selected dogs from all groups. The required 
dose of propofol for induction of anesthesia and the required isoflurane concentration for maintenance of anesthesia 
and the need for intraoperative fentanyl administration and extra postoperative pethidine analgesia were recorded. 
After statistical analysis, there were no significant differences between groups, regarding their anesthetic or analgesic 
requirements, that could be attributed to serum progesterone and/or allopregnanolone concentration. However, moder-
ate correlations within certain groups were noted. Serum progesterone or allopregnanolone concentrations do not seem 
to have an effect on anesthetic and analgesic requirements for ovariohysterectomy in the dog or any potential effect is 
weak enough to be masked by the action of anesthetic premedication and/or analgesic and/or anaesthetic drugs used.
Keywords: Progesterone, allopregnanolone, dog, anesthesia, ovariohysterectomy.
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INTRODUCTION
The anesthetic effect of steroid hormones was first reported by Hans Selye in 1941, who injected 
progesterone, desoxycorticosterone (DCA) and tes-
tosterone in rats (1941a). Selye documented deep se-
dation immediately after the first two intraperitoneal 
injections, and about an hour after the testosterone 
injection, with more pronounced effect on female rats 
and longer duration of anesthesia in rats that had been 
partially hepatectomised. The author also noted a syn-
ergistic action of progesterone with chloroform, in-
creasing the potency and duration of its action (Selye 
1941b). Tanifuji et al. (1986) injected male dogs with 
progesterone and reported a significant decrease in 
halothane’s minimum alveolar concentration (MAC), 
the same way Datta et al. reported decreased halo-
thane MAC in rabbits (1989). The most recent rele-
vant study was published by Shimizu et al. (2010) re-
garding the significant sevoflurane sparing effect of a 
single subcutaneous injection of progesterone for the 
loss of righting reflex (LRR) in male mice.
Decreases in MAC of volatile anesthetics attribut-
able to high concentrations of endogenous progester-
one were first recorded in animal species during preg-
nancy, specifically in ewes (Palahniuk et al. 1974) and 
in rats (Strout and Nahrwold 1981). Chinese research-
ers studied groups of women receiving anesthesia for 
termination of early pregnancy, and found decreased 
MAC for isoflurane, halothane and enflurane com-
pared with non-pregnant women (Chan et al. 1996; 
Gin and Chan 1994). Consequent studies found de-
creased thiopentone requirements for hypnosis and 
anesthesia and decreased propofol requirements for 
loss of consciousness in the same setting (Gin et al. 
1997; Mongardon et al. 2009), and the first study to 
prove a correlation between the decreased sevoflurane 
MAC and high progesterone concentration was pub-
lished in 2006 (Erden et al. 2005). Such correlations 
were shown again in women receiving anesthesia in 
2014. In specific, significant negative correlations 
were found between progesterone serum concentra-
tion and propofol requirements for loss of conscious-
ness in early pregnancy (Fu et al. 2014), as well as 
sevoflurane requirements in late pregnancy in women 
receiving anesthesia for caesarian section (Lee et al. 
2014).
Atkinson et al. (1965) tested 142 progesterone me-
tabolites on mice and discovered 67 to have anesthet-
ic properties, depending on their chemical structure. 
Progesterone metabolites site of action was discov-
ered to be the chloride ion channel of the GABA
A
 
receptor (Majewska et al. 1986), and the metabolite 
responsible for progesterone anesthetic effect was 
proven to be allopregnanolone (Korneyev and Costa 
1996).
The serum concentration of progesterone during 
the ovarian cycle in the dog is not greatly affected 
by pregnancy, i.e. even in the case of non-pregnancy, 
after proestrus and estrus, there is a 2 month period, 
ΠΕΡΙΛΗΨΗ. Η παρούσα μελέτη διερεύνησε την επίδραση της συγκέντρωσης της προγεστερόνης, είτε ενδογενούς 
κατά τον ωοθηκικό κύκλο και την κυοφορία, είτε εξωγενούς, καθώς και του ενεργού μεταβολίτη της αλλοπρεγνανολόνη, 
στις απαιτήσεις σε αναισθητικά και αναλγητικά φάρμακα και στην ένταση του μετεγχειρητικού πόνου για τη διεξαγωγή 
ωοθηκυστερεκτομής στον σκύλο. Περιελήφθησαν 150 υγιείς, θηλυκοί σκύλοι, οι οποίο προσκομίστηκαν στην Κλινική 
Ζώων Συντροφιάς του ΑΠΘ για ωοθηκυστερεκτομή και οι οποίοι κατανεμήθηκαν σε 6 ομάδες με βάση το στάδιο του 
ωοθηκικού κύκλου και την ενδεχόμενη ορμονική αγωγή που έλαβαν. Συγκεκριμένα, σχηματίστηκαν 6 ομάδες από 
ζώα στο στάδιο του ανοίστρου (ομάδα Α), ζώα σε άνοιστρο που έλαβαν προγεστερόνη ενδομυϊκώς (Απ), ζώα στο 
στάδιο του διοίστρου (Δ), ζώα σε δίοιστρο που έλαβαν υποδορίως αγλεπριστόνη (Δα), ζώα σε δίοιστρο που έλαβαν 
κάψουλες τριλοστάνης (Δτ) και ζώα σε κυοφορία 28-42 ημερών (Ε). Σε κάθε ζώο καταγράφηκαν οι απαιτήσεις σε 
προποφόλη για εγκατάσταση της γενικής αναισθησίας, οι απαιτήσεις σε ισοφλουράνιο για διατήρηση, οι απαιτήσεις 
σε επιπλέον αναλγητικά φάρμακα είτε διεγχειρητικά είτε μετεγχειρητικά και έγιναν μετεγχειρητικές εκτιμήσεις πόνου. 
Επίσης έγιναν αιμοληψίες σε συγκεκριμένες χρονικές στιγμές για ορμονολογικές αναλύσεις. Μετά τη στατιστική 
επεξεργασία των αποτελεσμάτων δε βρέθηκε στατιστικώς σημαντική διαφορά στις απαιτήσεις σε αναισθητικά ή σε 
αναλγητικά φάρμακα μεταξύ των ομάδων, ούτε στατιστικώς σημαντική συσχέτιση μεταξύ των απαιτήσεων αυτών 
και των συγκεντρώσεων στο αίμα της προγεστερόνης ή της αλλοπρεγνανολόνης, εκτός από 2 συσχετίσεις εντός 
συγκεκριμένων ομάδων. Συμπεραίνεται ότι οι συγκεντρώσεις προγεστερόνης ή αλλοπρεγνανολόνης στο αίμα δεν 
επηρεάζουν τις απαιτήσεις σε αναισθητικά ή αναλγητικά φάρμακα για τη διεξαγωγή ωοθηκυστερεκτομής στο σκύλο ή 
ότι ενδεχόμενη τέτοια επιρροή επικαλύπτεται από τη χορήγηση προαναισθητικής αγωγής και αναλγητικών φαρμάκων.
Λέξεις ευρετηρίασης: Προγεστερόνη, αλλοπρεγνανολόνη, σκύλος, αναισθησία, ωοθηκυστερεκτομή.
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called diestrus, during which the progesterone serum 
concentration is high (Concannon et al. 1975). This 
makes the dog an ideal candidate for the study of pro-
gesterone’s effect on anesthetic requirements, exclud-
ing any effects of a simultaneous pregnancy, which 
is known to lower volatile anesthetic requirements 
through changes in respiratory function (Cugell et al. 
1953). In theory, dogs undergoing surgery during a 
period of increased progesterone serum concentra-
tions (diestrus) should have lower anesthetic require-
ments than dogs in anestrus, when the concentration 
of progesterone is baseline (Concannon et al. 1975). 
The aim of the present study was to investigate the ef-
fects of increased progesterone serum concentrations 
on the anesthetic and analgesic requirements and on 
the intensity of postoperative pain in dogs undergoing 
ovariohysterectomy (OHE).
MATERIALS AND METHODS 
This double-blind, placebo-controlled, prospec-
tive clinical study was conducted at the Companion 
Animal Clinic, Veterinary School, Aristotle Universi-
ty of Thessaloniki, Greece and was approved by the 
university’s Ethics Committee (number of approval 
16/21-2-2012). All owners of animals included in the 
study were thoroughly informed and signed a consent 
form. The study included 150 female dogs that were 
admitted to the clinic for elective OHE. All dogs were 
classified as ASA status I (American Society of An-
esthesiologists physical status I) after clinical exam-
ination, complete blood count and examination of the 
genital system. Exclusion criteria were bodyweight 
lower than 4kg, age less than 8 months or more than 
8 years, abnormal findings in any examination per-
formed, positive results for leishmaniosis, ehrlichi-
osis or heartworm disease, previous hormonal treat-
ments for the manipulation of the ovarian cycle, blood 
serum progesterone concentration in the range 2-5 ng/
ml, pregnancy of less than 28 days, considered insig-
nificant, or more than 42, considered late pregnancy, 
as well as overt aggression, which complicates the 
hospitalization of the dog. 
The stage of the ovarian cycle was determined 
based on the reproductive history of each animal, the 
results of the examination of the genital system, micro-
scopic examination of vaginal smears and the serum 
progesterone concentration measurements. During 
the initial classification of the animals in groups, a 
commercial chromatographic progesterone kit was 
used (OVULATION® TEST, VIRBAC), and proges-
terone concentration was measured in blood serum 
later on. Animals with a progesterone concentration 
≤2 ng/ml were considered to be in anestrus and those 
with a concentration ≥5 ng/ml in diestrus. Pregnancy 
was diagnosed by abdominal ultrasonography (micro 
convex head, 5-10 MHz) and pregnancy duration was 
calculated using suitable software (EsaoteMyLabOne 
Vet, Esaote Europe B.V.). 
Groups, hormonal treatments, blood sampling 
and assays
All animals were hospitalized for a minimum of 
5 days and OHE was performed on day 3. Dogs in 
diestrus were assigned to 3 groups according to the 
hormonal treatment they received prior to surgery, 
dogs in anestrus were assigned to 2 groups accord-
ingly, and pregnant animals formed 1 group. Assign-
ment of animals in the respective groups was random, 
based on a random order table. All animals received, 
on days 1 and 2, two injections plus po capsules per 
day, either of hormonal treatments or placebos. Pla-
cebos were normal saline in the injections and empty 
capsule shells. In specific, the animals were assigned 
to 6 groups, as follows:
• group A (anestrus): dogs in anestrus that re-
ceived only placebos (n=40)
• group Ap (anestrus-progesterone): dogs in 
anestrus that received progesterone (GE-
STONE®, NORDIC PHARMA, 5mg/kg im 
SID) on days 1 and 2 and sc placebo injections 
and po placebo capsule cells (n=29).
• group D (diestrus): dogs in diestrus that re-
ceived only placebos (n= 23)
• group Da (diestrus-aglepristone): dogs in di-
estrus that received aglepristone (ALIZIN®, 
VIRBAC, 10mg/kg sc SID) on days 1 and 2 
and im placebo injections and po placebo cap-
sule cells (n= 17).
• group Dt (diestrus-trilostane): dogs in diestrus 
that received im and sc placebo injections and 
trilostane (VETORYL®, ALTAVET, one 60 
mg capsule in animals under 20 kg and two 
60 mg capsules in animals over 20 kg po BID) 
from day 1 till the morning of day 3 prior to 
the surgery (n= 11).
• group P (pregnancy): pregnant dogs that re-
ceived only placebos (n= 30)
Blood was collected 3 or 4 times for hormonal as-
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says. In all dogs, blood sample 1 was collected on day 
1, before administration of any hormonal treatment 
or placebo, sample 2 on day 3 just prior to surgery 
and after administration of all hormonal treatments or 
placebo, and sample 3 was collected 5 hours after the 
end of surgery. Sample 4 was collected only from an-
imals of groups D and Dt on day 5. Progesterone was 
measured in all animals in samples 1-3, allopregnano-
lone was measured in sample 2 in randomly selected 
animals from all groups and cortisol was measured in 
samples 1-4 in the animals of groups D and Dt.
Progesterone and cortisol concentrations were 
measured from blood serum using commercial elec-
trochemiluminescence kits (cobas® cortisol II, co-
bas® progesterone III, Elecsys 2010, Roche Diag-
nostics) and allopregnanolone was measured using a 
quantitative sandwich ELISA kit (www.mybiosource.
com).
Anesthetic management
All animals received their last meal on the night 
of day 2 and had free access to water up to 1 hour 
prior to administration of pre-anesthetic medication. 
Anesthetic management was supervised in all cases 
by the same anesthesiologist in charge (CK), who was 
blinded to the group the animal had been assigned to. 
After standard pre-anesthetic clinical examination, 
anesthetic premedication was administered intra-
muscularly consisting of acepromazine (0.05 mg/kg, 
CALMIVET®, VETOQUINOL) and pethidine (3 
mg/kg, FAMAR), followed immediately by a subcuta-
neous injection of carprofen (4 mg/kg, RIMADYL®, 
PFIZER). Thirty minutes later, the cephalic vein was 
cannulated and anesthesia was induced with propofol 
(PROPOFOL MCT/LCT/FRESENIUS 1%, FRESE-
NIUS KABI) administered intravenously in consecu-
tive doses of 1 mg/kg, approximately 1 minute apart, 
until intubation of the trachea was easily feasible. Af-
ter a cuffed endotracheal tube of appropriate diameter 
was in place, anesthesia was maintained with isoflu-
rane (Forrane, Baxter Healthcare Ltd) in 100% oxygen 
administered via a suitable anesthetic circuit. A circle 
rebreathing circuit was used for animals weighing 8 
kg or more and a non-rebreathing circuit for small-
er animals. Prophylactic cefuroxime (Zinacef, Glaxo 
Smith Kline) was then administered intravenously in 
all animals and an isotonic crystalloid solution (Lac-
tated Ringer’s injection, VIOSER) intravenous in-
fusion commenced and was continued until the end 
of surgery. After clipping and surgical preparation of 
the abdomen, the dog was transferred to the operat-
ing room, where monitoring commenced, consisting 
of electrocardiography, pulse oximetry, oscillometric 
blood pressure measurement (PC Scout, SpaceLabs 
Medical Inc.) and capnography and measurement of 
inspired and expired isoflurane concentrations (Cap-
nomacUltima, Datex-Engstrom). The monitors and 
gas analyzer were calibrated according to the man-
ufacturers’ instructions prior to the study. Heart rate 
(HR), respiratory rate (RR) and systolic, diastolic and 
mean blood pressures (BP), as well as end-tidal car-
bon dioxide and inspired and expired concentrations 
of isoflurane were constantly monitored and recorded 
every 5 minutes until the end of surgery. 
The vaporizer dial was initially set to deliver 2.5% 
isoflurane, but within a few minutes it was adjusted 
so as to provide the appropriate depth of surgical an-
esthesia, based on clinical assessment and monitored 
parameters. The depth of anesthesia was constantly 
evaluated by the anesthesiologist in charge (CK). In 
case of a 20% or more increase in HR and/or RR and/
or BP associated to noxious stimuli the depth of an-
esthesia was deemed inadequate and the isoflurane 
dial-setting was increased by 0.5% and the oxygen 
flow was temporarily increased to 4 L/min. If this 
manipulation proved ineffective in normalizing the 
value of the elevated parameter within 2-3 minutes, 
fentanyl (Fentanyl, Jannsen Pharmaceutica NV) was 
administered intravenously (0.002 mg/kg). When sur-
gery was completed, the administration of isoflurane 
and Lactated Ringer’s solution were discontinued and 
the dogs were allowed to recover. All operations were 
performed by the same team of surgeons.
Pain and sedation were evaluated 1, 3 and 5 hours 
after the end of surgery by the anesthesiologist in 
charge (CK) using a visual analogue scale (0%: no 
pain, 100%: worst pain imaginable) (0%: no sedation, 
100%: very heavily sedated). The pain assessment 
was based on the animals’ posture, movement and re-
sponse to palpation of the abdomen as described pre-
viously by Savvas et al. (2008). Intramuscular pethi-
dine was administered as rescue analgesia in case of 
a pain score higher than 50% in any assessment and 
repeated as needed.
Statistical analysis
The required number of animals in each group for 
an effect size of 0.3 and achieved power at least 0.8 
was calculated to be 19 (total number of animals 114).
All data were copied to digital spreadsheets (Mic-
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rosoft Excel 2007) and analyzed using the SPSS v.15 
software. Propofol requirements were calculated as 
total mg/kg, fentanyl and rescue analgesia require-
ments were recorded as “required” or “not required” 
and isoflurane requirements were calculated using 
the serial end- tidal concentrations recorded during 
surgery. Area under the curve (AUC) was calculated 
from those measurements, as proposed by Matthews 
et al. (1990), and then divided by the total duration of 
surgery, which varied between cases, to calculate the 
time standardized AUC (AUC_std) in each case, as 
described by Lawrence and De Lange(1997).
The normality of distribution of the data was 
checked using the Shapiro-Wilk normality test. A 
generalized linear model was used to evaluate differ-
ences between serum cortisol concentrations between 
groups D and Dt, as well as post operation pain scores 
between groups. Differences in propofol or isoflurane 
requirements were evaluated using one way analysis 
of variance (one way ANOVA), when evaluating 3 or 
more groups, and Student’s T-test when evaluating 2 
groups. A chi-squared test was used to evaluate dif-
ferences between groups regarding fentanyl or rescue 
analgesia requirements and possible correlations be-
tween various factors were checked using Pearson’s 
test. Values of p ≤ 0.05 were considered statistical-
ly significant. Descriptive statistics are presented as 
mean ± standard deviation.
RESULTS
The distributions of weight, age, duration of an-
esthesia, duration of surgery, propofol requirements 
for induction, isoflurane AUC_st, pain scores and se-
dation scores were found to be normal in all 6 groups 
(p = 0.103-0.983). There were no statistically sig-
nificant differences between groups regarding age, 
weight, duration of anesthesia and duration of surgery 
(p=0.131-0.653).
The serum progesterone concentrations in group 
Ap were significantly higher compared to those of 
group A after the im administration of progesterone 
(p<0.0005). The serum progesterone concentrations of 
group Dt were significantly lower than those of group 
D after the administration of trilostane (p<0.0005), 
but those of group Da were not significantly affected, 
when compared to group D, after the administration 
of aglepristone (p=0.31).
Propofol requirements ranged from 1 to 10 mg/kg 
with a mean of 3.88 ± 1.11 mg/kg. There was no sig-
nificant difference between main groups A, D and P 
(p = 0.713), diestrus groups D, Da and Dt (p = 0.378) 
or between anestrus groups A and Ap (p = 0.857). No 
correlation was found between propofol requirements 
and progesterone or allopregnanolone concentration, 
except a moderate inverse correlation between pro-
gesterone and propofol in group Da (r = -0.569, p = 
0.017).
Isoflurane requirements (AUC_std) ranged from 
0.7 to 2.68% with a mean of 1.65 ± 0.26%. No sig-
nificant difference was discovered after comparison 
between groups A, D and P (p = 0.109), groups D, Da 
and Dt (p = 0.623) or groups A and Ap (p = 0.601). 
There was no significant correlation between isoflu-
rane requirements and progesterone or allopregnano-
lone concentration, except a moderate inverse cor-
relation between progesterone and AUC_std in group 
P (r = -0.39, p = 0.033).
Figure 1.
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There were no significant differences between the 
groups regarding the incidence of fentanyl intra-op-
erative analgesia (p = 0.811) or the incidence of 
post-operative pethidine rescue analgesia (p = 0.858).
Concerning the post-operative pain scores, there 
were significant differences within each group over 
time (p<0.05). There were no significant differences 
between groups at the specific time points (p>0.05), 
with the exception of groups D and Dt, where signifi-
cantly higher scores were found in group Dt at all 3 
time points (1h p = 0.033, 3h p = 0.022, and 6h p = 
0.01). There was no statistically significant correla-
tion between pain scores (1h) and the progesterone 
(sample 2) (r=0.068, p=0.405) or allopregnanolone 
(r=0.064, p=0.565) concentrations.
Sedation scores did not differ significantly between 
groups at any time point (1h p=0.571, 3h p=0.198, 6h 
p=0.24).
The serum cortisol concentrations between groups 
D and Dt were significantly different in blood samples 
2 and 3 (p = 0.02 and p = 0.09), the concentrations of 
group D being higher, as opposed to samples 1 and 4 
(p = 0.566 and p = 0.075).
Figure 2.
Figure 3.
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Figure 4.
Figure 5.
DISCUSSION
The anesthetic effect of progesterone was discov-
ered in 1941 by Hans Selye (1941a) and its volatile 
anesthetic sparing effect was documented in dogs, 
rabbits and mice (Datta et al. 1989; Shimizu et al. 
2010; Tanifuji et al. 1986). High levels of endogenous 
progesterone have also been found to lower require-
ments for both volatile (Chan et al. 1996; Erden et al. 
2005; Gin and Chan 1994; Lee et al. 2014; Palahniuk 
et al. 1974; Strout and Nahrwold 1981) and injectable 
anesthetics (Fu et al. 2014; Gin et al. 1997; Mongar-
don et al. 2009) in various species, including humans. 
The present study, on the contrary, did not detect any 
difference in anesthetic or analgesic requirements in 
dogs, regardless of their baseline or high serum pro-
gesterone concentration.
Selye’s study was the first report of steroid an-
esthetic action and inspired all future studies, which 
eventually lead to the discovery and marketing of 
steroid anesthetics. However, very large doses of 
progesterone were used to achieve anesthesia and 
the blood progesterone concentrations were not re-
ported, so one cannot compare to the endogenous 
levels normally occurring during the ovarian cycle 
or pregnancy. Selye injected 100gr rats with 35mg 
of progesterone, nearly 350 mg/kg. Merryman et al. 
(1954) tried to reproduce Selye’s results in humans, 
by injecting 500mg of progesterone via infusion over 
1 hour, which caused sleep, not anesthesia, similar to 
Arafat et al. who reported sleep after a 400mg per os 
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administration (1988). It seems, therefore, that pro-
gesterone’s anesthetic effect requires large doses.
Progesterone’s MAC-reducing effect is reported in 
many studies (Datta et al. 1989; Erden et al. 2005; 
Lee et al. 2014; Selye 1941a; Shimizu et al. 2010; 
Tanifuji et al. 1986). The determination of MAC for 
volatile anesthetics, although a universal standard for 
anesthetic potency, is based on a time consuming lab-
oratory procedure and does not correspond to clini-
cal surgical conditions (Eger et al. 1965). It also does 
not take into consideration preanesthetic or analgesic 
drugs, which were used in all cases in our study, and 
could have masked progesterone’s anesthetic sparing 
effect. Other methodologies used in other studies, 
such as the modified sevoflurane pump used by Lee et 
al. to calculate the volume of liquid sevoflurane con-
sumed (2014), Mongardon et al.’s automated propofol 
infusion pump which calculated a predicted effect site 
concentration of propofol based on a pharmacokinetic 
algorithm (2009), and even LRR, as used by Shimitzu 
et al. on mice (2010), are considered laboratory pro-
cedures, not common clinical practice, and most are 
not even applicable to dogs.
The main finding of the present study is that in-
creased progesterone serum concentrations do not 
reduce the anesthetic and/or analgesic requirements 
or the intensity of post-operative pain in dogs un-
dergoing OHE. Since no anesthetic-sparing effect 
of progesterone was shown in the present study, no 
speculations can be made about the potential role of 
progesterone receptors (blocked by aglepristone in 
group Da). Moreover, pregnancy did not influence the 
anesthetic and/or analgesic requirements or the in-
tensity of post-operative pain. Pregnancy could have 
influenced via mechanisms unrelated to any potential 
action of progesterone (e.g. via changes in cardiovas-
cular or respiratory function or via mechanical factors 
related to the size of the gravid uterus affecting the 
function of other systems), but no significant effect 
was shown. Exogenous administration of progester-
one in our study did not induce any anesthetic-sparing 
effect, as one would expect since diestrus and preg-
nancy did not either induce such an effect.
The most comparable study to the present is the 
one by Tanifuji et al. (1986), as it was performed on 
dogs, and serum progesterone concentrations were 
measured. Tanifuji et al. injected 6 intact male dogs 
for 1 week with progesterone and calculated halo-
thane MAC using the tail clamp technique. They used 
2 dosages of progesterone, 2mg/kg and 5 mg/kg, and 
in both cases found halothane MAC to be significant-
ly decreased with a strong negative correlation to pro-
gesterone concentration. The progesterone concentra-
tion increased from control concentration 1.46 ± 0.22 
to 4.41 ± 0.7 and 8.91 ± 1.97 ng/ml. In our study, on 
the other hand, 29 female dogs were injected with 5 
mg/kg of progesterone for 2 days and the serum pro-
gesterone concentration increased from 1.24 ± 2.97 to 
36.44 ± 18.08 ng/ml, and still no statistically signifi-
cant difference in isoflurane requirements was found 
when compared to the anestrus group. The difference 
in the results could be attributed to shorter duration 
of progesterone administration to female dogs in the 
present study (2 days) compared to a longer time of 
administration (1 week) to male dogs in the study by 
Tanifuji et al. However, it is the authors’ opinion that a 
more likely explanation is that although progesterone 
shows MAC-reducing effects in a controlled setting, 
this effect is probably not intense enough to be detect-
ed during real-time surgery in the clinical setting.
The current study assessed the isoflurane require-
ments for performance of surgery in dogs, while in 
other relevant studies (Datta et al. 1989; Tanifuji et al. 
1986) the MAC calculation was used as a simulation 
of surgical stimulation. It is likely that high serum 
progesterone levels indeed have an anesthetic effect 
that can be detected in a laboratory environment, but 
this effect is probably not so intense as to be shown as 
anesthetic-sparing effect in the clinical setting during 
surgery. When trying to answer the question whether 
the veterinary anesthetist should be prepared for the 
possibility that lower doses of anesthetics/analge-
sics might be required for performance of surgery in 
a dog in diestrus or pregnancy as opposed to a dog 
in anestrus, the methodology of the current study is 
more helpful in giving the correct answer than studies 
based on MAC determination.
The negative correlation that was detected in 
group P between serum progesterone concentrations 
and isoflurane AUC_std could be a reflection of this 
anesthetic effect that high serum progesterone exerts 
and which is depicted in studies based on MAC de-
termination. Thus, there could be a real progesterone 
influence, at least in pregnant animals, but which, if 
present, seems to be too weak to be detected as re-
duced isoflurane requirements for maintenance of 
anesthesia, at least with the methodology used in the 
present study. Concerning the negative correlation 
detected between serum progesterone concentrations 
and propofol requirements in group Da, it could be 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 23/03/2020 06:18:19 |
J HELLENIC VET MED SOC 2019, 70(3)
ΠΕΚΕ 2019, 70(3)
1725CH. KOSTAKIS, T. ANAGNOSTOU, I. SAVVAS, CH.VERVERIDIS, A. KOURELIS
speculated that unavailability of cellular progester-
one receptors occupied by aglepristone could result 
in more progesterone being available for metabolism 
to allopregnanolone and thus for action on GABA 
receptors, leading to central nervous system depres-
sion. As in group P for isoflurane, however, it seems 
that any effect of aglepristone is not intense enough to 
be detected as a reduction in anesthetic/analgesic re-
quirements during surgery. The two correlations not-
ed in the two groups P and Da taken together could be 
considered as indications of a potential central ner-
vous system-depressive action of progesterone under 
specific circumstances that might be required for this 
action to be highlighted.
Trilostane was administered as it inhibits steroid 
synthesis from the adrenal cortex, including both cor-
tisol and progesterone (de Gier et al. 2011), since more 
specific progesterone synthesis inhibitors, like epos-
tane or azastane, were not available even for research 
purposes. Since trilostane inhibits cortisol synthesis, 
serum cortisol was monitored in groups D and Dt in 
blood samples 1 through 4. The serum cortisol con-
centration was significantly lower in group Dt com-
pared to group D in blood samples 2 and 3 (p = 0.002 
and p = 0.009 respectively) but was not lower in blood 
sample 4 (p = 0.075), indicating that cortisol synthesis 
returns to pre-administration levels within 48 hours 
after the last trilostane administration. This is the first 
report, to our knowledge, of cortisol’s synthesis re-
covery after trilostane administration in healthy dogs, 
since all relevant publications study cortisol synthesis 
inhibition in dogs suffering from Cushing’s disease. 
Post-operative pain scores were significantly high-
er in group Dt compared to those of control group D, 
but the incidence of fentanyl intra-operative analgesia 
or pethidine post-operative analgesia was not high-
er in group Dt. Detection of higher pain scores in a 
group of dogs (Dt) that received a drug with a “pro-al-
gesic action” (deprivation of synthesis of an endoge-
nous hormone with anti-inflammatory effects) can be 
viewed as a confirmation that the pain-assessing tool 
used in the present study was effective in discriminat-
ing animals in more pain.
A limitation of the current study is the small num-
ber of animals in group Dt in comparison to the other 
groups, owing to the fact that trilostane, the only ste-
roid synthesis inhibitor available, was commercially 
unavailable for a substantial period of the duration 
of the study. Regarding the methodology used in the 
current study for the detection of increased isoflurane 
requirements, instead of MAC calculation, it is the 
authors’ opinion that it is more representative of clin-
ical surgical conditions and would detect differences 
significant enough to suggest changes in the anesthet-
ic management of such cases. A similar methodology 
was used by Lawrence and De Lange (1997) in their 
human study on surgeries of varying duration, and by 
Columbano et al. (2012) in dogs undergoing OHE.
CONCLUSIONS
In conclusion, progesterone, either endogenous 
during the ovarian cycle and pregnancy, or admin-
istered intramuscularly, does not affect anesthetic or 
analgesic requirements for the performance of ovari-
ohysterectomy in dogs. In the author’s opinion, any 
anesthetic effect of progesterone is not intense enough 
and/or is masked by the use of pre-anesthetic med-
ications and analgesic drugs, such as non-steroidal 
anti-inflammatory drugs and opioids. Dogs receiving 
trilostane have significantly higher post-operative 
pain scores than dogs not receiving trilostane, so extra 
analgesic care is warranted in such animals undergo-
ing surgery.
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